<DOC>
	<DOCNO>NCT02448342</DOCNO>
	<brief_summary>Multi center , randomize control study , determine significant decrease rate heart failure re-hospitalizations occur follow-up period - ReDS guide treatment use adjunct standard care .</brief_summary>
	<brief_title>Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate Heart Failure Patients</brief_title>
	<detailed_description>The study design prospective , randomize , control , multi-center trial . Patients enrol index hospitalization Acutely decompensated Heart Failure ( ADHF ) follow minimum 3 month maximum 9 month ( last patient complete 3- month follow-up ) . Patients blind ReDS reading value . Recruitment take place either heart failure hospitalization ( see acceptance criterion ) within 10 day discharge qualify heart failure hospitalization . The Remote Dielectric Sensing ( ReDS ) device provide noninvasive measurement lung fluid content . It comprise wearable vest embed sensor bedside console . A measurement reading provide within 90sec . Results share treat physician via secure web portal . Study objective determine significant decrease rate heart failure re-hospitalizations occurs entire follow-up period ReDS guide treatment use adjunct standard care ( SOC ) . Patients randomize two group hospital discharge : ReDS SOC vs. SOC . Patient randomize treatment arm perform daily ReDS measurement home . Treating physician follow patient ' measurement secure dedicated web site . Notification message automatically send system physician certain threshold cross ( threshold physician adjustable ) . Medications adjust accord define guideline . Patients randomize control arm follow medically manage accord standard care guideline . Both arm schedule clinical visit phone follow : - A follow phone call , per current treatment guideline , attempt within 2 day hospital discharge obtain information regard medication reconciliation , Heart Failure ( HF ) symptoms HF management issue ( e.g. , dietary restriction ) . - An outpatient clinic visit schedule week hospital discharge . - Study follow-up visit 1 3 month . Follow-up continue enrolled subject 6 9 month last subject pas 3-month follow-up window . - At study follow-up visit , patient undergo complete physical exam , vital sign , collection readmission standard blood test QOL questionnaire .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Main 1 . Patient sign informed consent authorization use disclose health information . 2 . Patient 's physical condition enables sit lay minimal assistance . 3 . Diagnosis HF , preserve reduced LVEF , make least 30 day prior enrollment . 4 . Patients LVEF &lt; 40 % must treat least 30 day prior enrollment diuretic betablocker ( unless intolerant contraindicate ) ACEinhibitor ARB ( unless intolerant contraindicate ) . 5 . Patient hospitalize ADHF require significant alteration heart failure treatment ( i.e . diuretic vasoactive drug ) 10 day postdischarge ADHF admission . 6 . BNP ≥ 350 pg/ml ( NT pro BNP &gt; 1400 pg/ml ) enrollment ( within 24h ) and/or ≥750 pg/ml time hospital stay ( NTpro BNP &gt; 3000 pg/ml ) . Note patient enrol clinic visit rather hospitalization , BNP index admission reference . Main 1 . Patient cardiac transplantation VAD implantation . 2 . CRT implantation within 90 day prior screen plan implantation study duration . 3 . Current past Pulmonary Embolism right lung . Notes : ( ) Past pulmonary embolus define identify &lt; 6 month prior enrollment . ( ii ) past current tiny , microscopic pulmonary emboli exclude patient . ( iii ) ventilationperfusion ( VQ ) scan show lung clear , exclusion criterion meet . 4 . Diagnosis Severe Pulmonary Hypertension . 5 . STEMI CABG within 30 day screen visit . Note : Type 2 MI due ADHF exclusion . 6 . Chronic renal failure CrCl &lt; 25mL/min , calculate CockcroftGault formula . 7 . Chronic home IV therapy cardiac inotropes diuretic 8 . Physical deformity thorax area lesion may prevent proper vest application adjustment ( Severe scoliosis/ sensitive sternotomy lesion etc. ) . 9 . Illness/ Condition may aggravate cause significant discomfort application vest ( Rib fracture , without flail chest , Severe Osteoporosis ) . 10 . Impaired cognitive ability state may prevent full compliance study protocol , accord investigator 's assessment . 11 . Patient 's habitus range due one following : Height le 155cm high 195cm ( 5.1 ; 6.4 foot respectively ) . BMI less 22 36 . In case BMI 3638 , measure vest ruler &gt; =4 , exclusion criterion meet . 12 . Congenital heart malformation intrathoracic mass would affect right lung anatomy ( Dextrocardia , Lung Carcinoma etc . ) include pacemaker box right side chest . 13 . Severe COPD , define chronic continuous home use O2 ( O2 dependancy ) and/ oral steroid . Continuous define 24hours day , every day . 14 . Severe disease / condition life expectancy &lt; 6 month accord investigator 's assessment . 15 . Patient enrol another interventional study permission study manager ( observational registry exclude ) . 16 . Patient HF manage remotely another monitoring device program ( example : Pulmonary/ Lt Atrial pressure monitoring , Weight scale , BNP bioimpedance ) . 17 . Prisoners ward state</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Remote Patient Monitoring</keyword>
	<keyword>Non Invasive Lung Fluid Status Monitor</keyword>
</DOC>